Norvir and Joint effusion - a phase IV clinical study of FDA data

Summary:

Joint effusion is reported as a side effect among people who take Norvir (ritonavir), especially for people who are male, 40-49 old, have been taking the drug for 1 - 6 months also take Bactrim, and have Hepatic steatosis.

The phase IV clinical study analyzes which people have Joint effusion when taking Norvir. It is created by eHealthMe based on reports of 24,715 people who have side effects when taking Norvir from the FDA, and is updated regularly.

What is Norvir?

Norvir has active ingredients of ritonavir. It is often used in hiv infection. eHealthMe is studying from 24,973 Norvir users. Check the latest studies of Norvir.

What is Joint effusion?

Joint effusion (presence of extra fluid in joint covering) is found to be associated with 869 drugs and 750 conditions by eHealthMe. Check the latest studies of Joint effusion.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

24,715 people reported to have side effects when taking Norvir.
Among them, 12 people (0.05%) have Joint effusion.

Among these 12 people:

How long have people been on Norvir when they have Joint effusion? *

What is the gender of people who have Joint effusion when taking Norvir? *

female: 16.67 %
male: 83.33 %

What is the age of people who have Joint effusion when taking Norvir? *

What are other drugs people take besides Norvir? *

What are other side effects people have besides Joint effusion? *

Aseptic Necrosis (the death of bone tissue due to a lack of blood supply): 8 people, 66.67%
Joint Pain: 6 people, 50.00%
Acute Kidney Failure: 2 people, 16.67%
High Blood Pressure: 2 people, 16.67%
Gallstones (stone formation by bile component): 1 person, 8.33%
Anaemia Macrocytic (a macrocytic class of anaemia): 1 person, 8.33%
Aseptic Necrosis Bone: 1 person, 8.33%
Bone Marrow Oedema (inflammation that causes much than the needed fluid in a bone): 1 person, 8.33%
Broken Bone: 1 person, 8.33%
Drug Ineffective: 1 person, 8.33%

What are the existing conditions these people have? *

Hiv Test Positive: 1 person, 8.33%
Hepatic Steatosis (fatty liver disease): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Norvir and have Joint effusion?

- Check whether Joint effusion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Norvir:

Norvir (24,973 reports)

Joint effusion treatments and more:

Joint effusion (9,947 reports)

Browse all side effects of Norvir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Joint effusion:

Joint effusion (869 drugs)

Browse all the conditions that are associated with Joint effusion:

Joint effusion (750 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ritonavir (the active ingredients of Norvir) and Norvir (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.